Knockdown orectopic expression of SOX2 modulates the degree of apoptosis observed following oncogenewithdrawal and promotes drug resistance, pointing to a novel homeostatic mechanism thatmay contribute to cellular adaptation to the withdrawal of growth factor signaling,which underlies most approaches to targeted cancer therapy. Here, SOX2 is linked to cancer.